Head to head
BeautiFill vs EON (2026)
Compare purchase costs, running costs and the evidence behind each device.
Read the comparison overview
- Purchase cost
- Catalog new-price ranges: BeautiFill, $150k–$200k; EON, $175k–$250k. Check the source notes and request current quotes.
- Practice fit
- Both are listed under body contouring. Check each model’s US regulatory status and labeled indications for your intended use.
Body Contouring
View full device profile →Body Contouring
View full device profile →Price comparison
New price range
- Alma Lasers BeautiFill
- $150k–$200kSource not documented
- Dominion Aesthetic Technologies EON
- $175k–$250kSource not documented
Used asking range
- Alma Lasers BeautiFill
- $60k–$100kSource not documented
- Dominion Aesthetic Technologies EON
- Not published
Payback calculator
- Alma Lasers BeautiFill
- View ROI calculator
- Dominion Aesthetic Technologies EON
- View ROI calculator
Next step
Consumable economics
Consumable cost / lock-in
- Alma Lasers BeautiFill
- Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
- Dominion Aesthetic Technologies EON
- There are no physical disposables — no cards, tips, pads, or membranes. However, a manufacturer usage charge per treated cm² has been described publicly by Dominion's leadership (Dermatology Times interview), so treatment volume is metered commercially even without a disposable. The current schedule is not published — obtain it in writing from Dominion before modeling per-session margin. — card-metered — license cards or dongles gate treatments
Service cost
- Alma Lasers BeautiFill
- Not published
- Dominion Aesthetic Technologies EON
- Not published
FDA clearance
FDA status & indication
- Alma Lasers BeautiFill
- FDA ClearedK171242
Read FDA indication wording
“The Alma LipoFlow System is used in the aspiration, harvesting, filtering and transferring of autologous adipose tissue and infiltration for aesthetic body contouring. If the harvested fat is to be re-implanted, the harvested fat is only to be used without any additional manipulation.”
- Dominion Aesthetic Technologies EON
Read FDA indication wording
“The eon™ FR (1064nm laser) is intended for non-invasive lipolysis of the abdomen to achieve disruption of adipocyte cells intended for non-invasive aesthetic use to achieve a desired aesthetic effect. It is intended for individuals with a Body Mass Index (BMI) of 30 or less.”
Which chains run each
Chain adoption
- Alma Lasers BeautiFill
- 0 recorded pairings
- Dominion Aesthetic Technologies EON
- 1 recorded pairing
Chains using it
- Alma Lasers BeautiFill
- —
- Dominion Aesthetic Technologies EON
- SKINNEY Medspa(Confirmed)
Approved reviews
- Alma Lasers BeautiFill
- 0
- Dominion Aesthetic Technologies EON
- 0
Specs and platform
Manufacturer
- Alma Lasers BeautiFill
- Alma Lasers
- Dominion Aesthetic Technologies EON
- Dominion Aesthetic Technologies
Built by (OEM)
- Alma Lasers BeautiFill
- Alma Lasers Ltd.
- Dominion Aesthetic Technologies EON
- Dominion Aesthetic Technologies
Category
- Alma Lasers BeautiFill
- Body Contouring
- Dominion Aesthetic Technologies EON
- Body Contouring
Technology
- Alma Lasers BeautiFill
- 1470nm laser lipo + fat transfer (Injection lipolysis / laser lipo)
- Dominion Aesthetic Technologies EON
- Robotic touchless 1064nm laser (Injection lipolysis / laser lipo)
Launch year
- Alma Lasers BeautiFill
- 2019
- Dominion Aesthetic Technologies EON
- 2019
Status
- Alma Lasers BeautiFill
- Current
- Dominion Aesthetic Technologies EON
- Current
Manufacturer source record
- Alma Lasers BeautiFill
- No linked source on file.
- Dominion Aesthetic Technologies EON
- No linked source on file.
Current alternatives
Current catalog models in related categories. Confirm availability and configuration with the supplier.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.